NASDAQ:ROIV

Roivant Sciences Stock News

etoro logo Buy ROIV
*Your capital is at risk
$31.25
-0.180 (-0.573%)
At Close: Jun 22, 2026
Campbell and CO Investment Adviser LLC trimmed its holdings in Roivant Sciences Ltd. (NASDAQ: ROIV) by 65.8% during the third quarter, according to its most recent disclosure with the Securities and E
Roivant Sciences (NASDAQ: ROIV - Get Free Report) and NovAccess Global (OTCMKTS:XSNX - Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two compa
Roivant Sciences Ltd. (ROIV) Presents at 44th Annual J.P.
Roivant Sciences Ltd. (ROIV) Q2 2025 Earnings Call Transcript
Stock News Street sets 2026 expectations: Wall Street sees the S&P 500 posting modest-to-mid-teens gains in 2026 after a 16.39% rise in 2025, with AI leaders li
Roivant Sciences Ltd. (NASDAQ: ROIV - Get Free Report) CEO Eric Venker sold 75,000 shares of the stock in a transaction on Wednesday, December 24th. The stock was sold at an average price of $22.53, f
The Goldman Sachs Mid Cap Growth Fund underperformed its benchmark, the Russell Midcap Growth Index (net), during the quarter. United Rentals, Inc. released a positive quarterly earnings report, surpa
Stock News Ford pivots from pure EVs, takes $19.5B charge: Ford Motor (F) will record about $19.5 billion in special items tied to a pullback from all-electric
Roivant Sciences Ltd. (NASDAQ: ROIV - Get Free Report) CEO Eric Venker sold 200,000 shares of the stock in a transaction on Tuesday, December 9th. The shares were sold at an average price of $20.85, f
Roivant Sciences Ltd. (ROIV) Analyst/Investor Day Transcript
Roivant (NASDAQ: ROIV) outlined accelerated timelines and expanded commercial ambitions for several late-stage programs.
BASEL, Switzerland and LONDON and NEW YORK, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Roivant (Nasdaq: ROIV) today is hosting an Investor Day in New York City. Roivant leadership will highlight key pipeline u
Roivant Sciences Ltd. (NASDAQ: ROIV - Get Free Report) shares hit a new 52-week high on Friday. The stock traded as high as $21.40 and last traded at $21.1550, with a volume of 1946 shares. The stock
Representative Lisa C. McClain (R-Michigan) recently sold shares of Roivant Sciences Ltd. (NASDAQ: ROIV). In a filing disclosed on November 21st, the Representative disclosed that they had sold betwee
Roivant Sciences Ltd. ( ROIV ) Jefferies London Healthcare Conference 2025 November 18, 2025 12:00 PM EST Company Participants Matthew Gline - CEO & Director Conference Call Participants Yuchen Ding -
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE